Tenaya Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Tenaya Therapeutics, Inc. (TNYA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are TNYA insiders buying or selling?
In the last 12 months, Tenaya Therapeutics, Inc. insiders reported 0 open-market purchases ($0) and 14 sales ($6.0M) — net selling of $6.0M. Since August 2021, Trabud has recorded 57 Form 4 filings for TNYA: 18 buys ($161.7M) and 39 sells ($6.4M).
Source: SEC EDGAR Form 4
What stands out
- No Tenaya Therapeutics, Inc. insider made an open-market purchase in the last 12 months; the 14 reported open-market sales totaled $6.0M.
Key Statistics (August 2021 – Aug 18, 2026)
Total Form 4 filings
57
SEC EDGAR
Insider filers
11
Insider buys (18)
$161.7M
Insider sells (39)
$6.4M
Insider sentiment
Net buyingNet insider flow of $155.3M in net buying since August 2021, and $6.0M in net selling over the last 12 months.
Recent TNYA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Faraz Ali | Chief Executive Officer | Sale | 22.2K | $0.71 | $15.8K | SEC ↗ |
| Aug 18, 2026 | Whittemore Tingley | Chief Medical Officer | Sale | 7.4K | $0.71 | $5.3K | SEC ↗ |
| May 19, 2026 | Faraz Ali | Chief Executive Officer | Sale | 3.4K | $0.79 | $2.7K | SEC ↗ |
| May 19, 2026 | Whittemore Tingley | Chief Medical Officer | Sale | 3.1K | $0.79 | $2.5K | SEC ↗ |
| May 19, 2026 | Tomohiro Higa | SVP, Finance | Sale | 1.5K | $0.79 | $1.2K | SEC ↗ |
| Feb 26, 2026 | Tim Kutzkey | 10% Owner | Sale | 4.2M | $0.57 | $2.4M | SEC ↗ |
| Feb 24, 2026 | Tim Kutzkey | 10% Owner | Sale | 829.7K | $0.61 | $504.8K | SEC ↗ |
| Feb 18, 2026 | Tomohiro Higa | SVP, Finance | Sale | 3.5K | $0.64 | $2.2K | SEC ↗ |
| Feb 18, 2026 | Faraz Ali | Chief Executive Officer | Sale | 14.9K | $0.64 | $9.6K | SEC ↗ |
| Feb 18, 2026 | Whittemore Tingley | Chief Medical Officer | Sale | 5.2K | $0.64 | $3.3K | SEC ↗ |
| Feb 12, 2026 | Tim Kutzkey | 10% Owner | Sale | 4.4M | $0.69 | $3.0M | SEC ↗ |
| Nov 18, 2025 | Tomohiro Higa | SVP, Finance | Sale | 1.4K | $1.33 | $1.8K | SEC ↗ |
| Nov 18, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 2.9K | $1.33 | $3.8K | SEC ↗ |
| Nov 18, 2025 | Faraz Ali | Chief Executive Officer | Sale | 3.1K | $1.33 | $4.2K | SEC ↗ |
| Aug 19, 2025 | Tomohiro Higa | SVP, Finance | Sale | 3.0K | $1.25 | $3.7K | SEC ↗ |
| Aug 19, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 5.1K | $1.25 | $6.3K | SEC ↗ |
| Aug 19, 2025 | Faraz Ali | Chief Executive Officer | Sale | 14.5K | $1.25 | $18.2K | SEC ↗ |
| May 16, 2025 | Tomohiro Higa | SVP, Finance | Sale | 1.4K | $0.44 | $615.35 | SEC ↗ |
| May 16, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 2.9K | $0.44 | $1.3K | SEC ↗ |
| May 16, 2025 | Faraz Ali | Chief Executive Officer | Sale | 3.2K | $0.44 | $1.4K | SEC ↗ |
| Mar 11, 2025 | Tomohiro Higa | SVP, Finance | Sale | 2.5K | $0.54 | $1.3K | SEC ↗ |
| Mar 11, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 7.4K | $0.54 | $4.0K | SEC ↗ |
| Mar 11, 2025 | Faraz Ali | Chief Executive Officer | Sale | 9.7K | $0.54 | $5.2K | SEC ↗ |
| Mar 8, 2025 | COLUMN GROUP III GP, LP | 10% Owner | Purchase | 35.7M | $0.70 | $25.0M | SEC ↗ |
| Mar 8, 2025 | David V Goeddel | Director, 10% Owner | Purchase | 35.7M | $0.70 | $25.0M | SEC ↗ |
Showing the 25 most recent of 57 Form 4 filings for Tenaya Therapeutics, Inc..
Most active TNYA insiders
- COLUMN GROUP III GP, LP10 filings
- Faraz Ali10 filings
- Whittemore Tingley10 filings
- David V Goeddel7 filings
- Timothy Hoey6 filings
Ask anything about TNYA insider activity
Use Trabud's AI agent to query Tenaya Therapeutics, Inc.'s Form 4 history in plain English — "Show me TNYA CEO purchases this year" or compare it against any other ticker.
Open the AI agentTNYA insider trading FAQ
Are Tenaya Therapeutics, Inc. insiders buying or selling?
In the last 12 months, Tenaya Therapeutics, Inc. insiders reported 0 open-market purchases ($0) and 14 sales ($6.0M) — net selling of $6.0M. Since August 2021, Trabud has recorded 57 Form 4 filings for TNYA: 18 buys ($161.7M) and 39 sells ($6.4M). Over the full record that is net buying of $155.3M.
How many insiders trade TNYA stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Tenaya Therapeutics, Inc.. The most recent filing was accepted on Aug 18, 2026.
Where does Trabud get TNYA insider trading data?
All TNYA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.